Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)verified

SPAGO.ST

Price:

$0.138

Market Cap:

$51.19M

Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.

Industry

Biotechnology

IPO Date

2013-01-16

Stock Exchange

STO

Ticker

SPAGO.ST

The Enterprise Value as of May 2026 (TTM) for Spago Nanomedical AB (publ) (SPAGO.ST) is 21.52M

According to Spago Nanomedical AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 21.52M. This represents a change of -65.45% compared to the average of 62.28M of the last 4 quarters.

Spago Nanomedical AB (publ) (SPAGO.ST) Historical Enterprise Value (quarterly & annually)

How has SPAGO.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Spago Nanomedical AB (publ) over the last ten years is 242.17M. The current 21.52M Enterprise Value has changed 788.45% with respect to the historical average. Over the past ten years (40 quarters), SPAGO.ST's Enterprise Value was at its highest in in the December 2019 quarter at 631.06M. The Enterprise Value was at its lowest in in the December 2025 quarter at 23.19M.

Quarterly (TTM)
Annual

Average

242.17M

Median

196.17M

Minimum

13.99M

Maximum

663.22M

Spago Nanomedical AB (publ) (SPAGO.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Spago Nanomedical AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 183.65%

Maximum Annual Enterprise Value = 663.22M

Minimum Annual Increase = -93.68%

Minimum Annual Enterprise Value = 13.99M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202513.99M-44.98%
202425.43M34.84%
202318.86M-14.57%
202222.08M-93.68%
2021349.10M-24.99%
2020465.38M-29.83%
2019663.22M40.74%
2018471.25M183.65%
2017166.14M-26.56%
2016226.21M28.38%

Spago Nanomedical AB (publ) (SPAGO.ST) Average Enterprise Value

How has SPAGO.ST Enterprise Value performed in the past?

The current Enterprise Value of Spago Nanomedical AB (publ) (SPAGO.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

19.43M

5-year avg

85.89M

10-year avg

242.17M

Spago Nanomedical AB (publ) (SPAGO.ST) Enterprise Value vs. Peers

How is SPAGO.ST’s Enterprise Value compared to its peers?

Spago Nanomedical AB (publ)’s Enterprise Value is less than Sprint Bioscience AB (publ) (253.15M), greater than Alligator Bioscience AB (publ) (7.09M), less than AcouSort AB (publ) (87.04M), greater than Lipigon Pharmaceuticals AB (publ) (-8820352.00), less than Simris Alg AB (publ) (140.59M), greater than SpectraCure AB (publ) (15.58M), less than OncoZenge AB (publ) (97.07M), less than Scandinavian Real Heart AB (Publ) (73.82M), less than Pila Pharma AB (publ) (63.13M), less than Active Biotech AB (publ) (26.45M),

Build a custom stock screener for Spago Nanomedical AB (publ) (SPAGO.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spago Nanomedical AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Spago Nanomedical AB (publ) (SPAGO.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Spago Nanomedical AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Spago Nanomedical AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for Spago Nanomedical AB (publ) (SPAGO.ST)?

What is the 3-year average Enterprise Value for Spago Nanomedical AB (publ) (SPAGO.ST)?

What is the 5-year average Enterprise Value for Spago Nanomedical AB (publ) (SPAGO.ST)?

How does the current Enterprise Value for Spago Nanomedical AB (publ) (SPAGO.ST) compare to its historical average?